TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma.

M A Dickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.